Cowen downgraded PTC Therapeutics (NASDAQ: PTCT) from Outperform ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Downgrades

Jefferies Cuts PTC Therapeutics (PTCT) Target to $8March 1, 2016 9:13 AM RBC Cuts PTC Therapeutics (PTCT) Price Target by Nearly 20%March 1, 2016 8:54 AM Wedbush Downgrades PTC Therapeutics (PTCT) to NeutralMarch 1, 2016 7:29 AM PTC Therapeutics (PTCT) Misses Q4 EPS by 25cFebruary 29, 2016 4:02 PM PTC Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate UpdateFebruary 29, 2016 4:01 PM Germany Seeks PTC Therapeutics (PTCT) Translarna Discount - OppenheimerFebruary 29, 2016 9:32 AM BofA/Merrill Lynch Downgrades PTC Therapeutics (PTCT) to NeutralFebruary 29, 2016 8:58 AM PTC Therapeutics (PTCT) Offers Update on German Pricing and Reimbursement Process for TranslarnaFebruary 26, 2016 4:02 PM PTC Therapeutics Provides Update on German pricing and Reimbursement Process for Translarna™ (ataluren)February 26, 2016 4:01 PM PTC Therapeutics (PTCT) Shares Decline; German Reimbursement Arbitration Panel Said to Cut Price of Ataluren by 65%February 26, 2016 3:37 PM